Carolina Oncology Specialists — Hickory, North Carolina

Carolina Oncology Specialists is a clinical research site located in Hickory, North Carolina, United States 28602.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Carolina Oncology Specialists has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: NSCLC Stage IV.

Sponsors: ImmunityBio, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Hickory

Browse all research sites in North Carolina · View every site in Hickory

• Catawba Memorial Hospital
• PMG Research of Hickory
• Research Site
• GSK Investigational Site
• Pfizer Investigational Site
• Clinical Trials of America
• Graystone Eye
• Novartis Investigative Site
• Local Institution
• Unifour Medical Research Associates
• Accellacare Hickory
• Clinical Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carolina Oncology Specialists?

Carolina Oncology Specialists has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carolina Oncology Specialists conducted?

Carolina Oncology Specialists has 1 clinical trials on record, with 1 currently active. Their work covers NSCLC Stage IV.

Is Carolina Oncology Specialists accredited by Crixeo Clinical Trials?

Carolina Oncology Specialists has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Carolina Oncology Specialists?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.